Dual intra-articular injections of corticosteroid and hyaluronic acid versus single corticosteroid injection for ankle osteoarthritis: a randomized comparative trial.

IF 2.4 3区 医学 Q2 ORTHOPEDICS BMC Musculoskeletal Disorders Pub Date : 2025-03-11 DOI:10.1186/s12891-025-08488-0
Inha Woo, Jeong-Jin Park, Chul Hyun Park
{"title":"Dual intra-articular injections of corticosteroid and hyaluronic acid versus single corticosteroid injection for ankle osteoarthritis: a randomized comparative trial.","authors":"Inha Woo, Jeong-Jin Park, Chul Hyun Park","doi":"10.1186/s12891-025-08488-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intra-articular corticosteroid injection is commonly used for pain relief in ankle osteoarthritis (OA). The effects of corticosteroids (CS) are short-lived, whereas hyaluronic acid (HA) have longer-lasting effects. The objective was to compare the efficacy of dual injections of CS and HA to CS alone. We hypothesized that intra-articular injections of dual agents would be more effective than CS alone.</p><p><strong>Methods: </strong>A single-blind, randomized, controlled trial was designed to investigate this hypothesis. 135 patients with ankle OA were enrolled into an intra-articular CS injection group (CS group, n = 61) or dual HA plus CS injection group (CS + HA group, n = 74). The CS group received 1 mL of corticosteroid and 1 mL of 0.5% bupivacaine and 1 mL of normal saline once, and the CS + HA group received 3 mL of a total of 5 mL mixtures containing 2 mL of HA, or 1 mL of corticosteroid, 0.5% bupivacaine, and normal saline in the first week, followed by 2 mL of HA in the second and third weeks. Clinical evaluations were performed before injection, 6 and 12 weeks after the first injections. The Ankle Osteoarthritis Scale (AOS) was used as the primary outcome measure, and the Visual Analogue Scale (VAS), Short Form Health Survey (SF-36), and complications were used as secondary outcomes.</p><p><strong>Results: </strong>The mean AOS change from baseline was significantly greater in the CS + HA group than in the CS group at 6 (p ≤ 0.01) and 12 weeks (p ≤ 0.01). The mean VAS change from baseline was significantly greater in the CS group than in the CS + HA group at 6 weeks (p = 0.023), but not at 12 weeks (p = 0.731). The mean SF-36 change from baseline was not significant between the CS and CS + HA groups at 6 (p = 0.416) and 12 weeks (p = 0.215).</p><p><strong>Conclusions: </strong>The combination of corticosteroid and HA injection is more effective than corticosteroid alone in relieving pain in ankle OA.</p><p><strong>Trial registration: </strong>Clinical Research Information Service in South Korea, KCT0008690 // Registration Date (First Posted): July 21th, 2023 ( http://cris.nih.go.kr ).</p>","PeriodicalId":9189,"journal":{"name":"BMC Musculoskeletal Disorders","volume":"26 1","pages":"239"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11895146/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Musculoskeletal Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12891-025-08488-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Intra-articular corticosteroid injection is commonly used for pain relief in ankle osteoarthritis (OA). The effects of corticosteroids (CS) are short-lived, whereas hyaluronic acid (HA) have longer-lasting effects. The objective was to compare the efficacy of dual injections of CS and HA to CS alone. We hypothesized that intra-articular injections of dual agents would be more effective than CS alone.

Methods: A single-blind, randomized, controlled trial was designed to investigate this hypothesis. 135 patients with ankle OA were enrolled into an intra-articular CS injection group (CS group, n = 61) or dual HA plus CS injection group (CS + HA group, n = 74). The CS group received 1 mL of corticosteroid and 1 mL of 0.5% bupivacaine and 1 mL of normal saline once, and the CS + HA group received 3 mL of a total of 5 mL mixtures containing 2 mL of HA, or 1 mL of corticosteroid, 0.5% bupivacaine, and normal saline in the first week, followed by 2 mL of HA in the second and third weeks. Clinical evaluations were performed before injection, 6 and 12 weeks after the first injections. The Ankle Osteoarthritis Scale (AOS) was used as the primary outcome measure, and the Visual Analogue Scale (VAS), Short Form Health Survey (SF-36), and complications were used as secondary outcomes.

Results: The mean AOS change from baseline was significantly greater in the CS + HA group than in the CS group at 6 (p ≤ 0.01) and 12 weeks (p ≤ 0.01). The mean VAS change from baseline was significantly greater in the CS group than in the CS + HA group at 6 weeks (p = 0.023), but not at 12 weeks (p = 0.731). The mean SF-36 change from baseline was not significant between the CS and CS + HA groups at 6 (p = 0.416) and 12 weeks (p = 0.215).

Conclusions: The combination of corticosteroid and HA injection is more effective than corticosteroid alone in relieving pain in ankle OA.

Trial registration: Clinical Research Information Service in South Korea, KCT0008690 // Registration Date (First Posted): July 21th, 2023 ( http://cris.nih.go.kr ).

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
关节内双注射皮质类固醇和透明质酸与单注射皮质类固醇治疗踝关节骨关节炎:一项随机比较试验。
背景:关节内皮质类固醇注射通常用于缓解踝关节骨关节炎(OA)的疼痛。皮质类固醇(CS)的作用是短暂的,而透明质酸(HA)有更持久的作用。目的是比较双注射CS和HA与单独注射CS的疗效。我们假设关节内注射双重药物比单独使用CS更有效。方法:采用单盲、随机、对照试验对该假设进行验证。将135例踝关节OA患者分为关节内注射CS组(CS组,n = 61)和双HA + CS注射组(CS + HA组,n = 74)。CS组接受1 mL皮质类固醇+ 1 mL 0.5%布比卡因+ 1 mL生理盐水1次,CS + HA组在第一周接受3 mL共5 mL含2ml HA的混合物,或1 mL皮质类固醇+ 0.5%布比卡因+生理盐水,第二周和第三周分别接受2ml HA。分别于注射前、首次注射后6周和12周进行临床评价。踝关节骨关节炎量表(AOS)作为主要结局指标,视觉模拟量表(VAS)、简短健康调查量表(SF-36)和并发症作为次要结局指标。结果:CS + HA组6周和12周的平均AOS较基线变化显著大于CS组(p≤0.01)。CS组在6周时较基线的平均VAS变化显著大于CS + HA组(p = 0.023),但在12周时差异无统计学意义(p = 0.731)。CS组和CS + HA组在6周(p = 0.416)和12周(p = 0.215)时,SF-36与基线的平均变化无统计学意义。结论:糖皮质激素联合透明质酸注射液治疗踝关节骨性关节炎的疗效优于单用糖皮质激素。试验注册:韩国临床研究信息服务,KCT0008690 //注册日期(首次发布):2023年7月21日(http://cris.nih.go.kr)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders 医学-风湿病学
CiteScore
3.80
自引率
8.70%
发文量
1017
审稿时长
3-6 weeks
期刊介绍: BMC Musculoskeletal Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of musculoskeletal disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The scope of the Journal covers research into rheumatic diseases where the primary focus relates specifically to a component(s) of the musculoskeletal system.
期刊最新文献
Immediate radiographic reduction loss but preserved clinical outcomes after hardware removal in lateral clavicle fractures treated with plate fixation and coracoclavicular augmentation. BMI-stratified performance of native CT hounsfield units in the proximal femur for osteoporosis detection and fracture association. Pathological features of the lateral joint capsule and lateral retinaculum in lateral patellar compression syndrome: a retrospective case-control study. The predictive effect of Kellgren-Lawrence grade and joint space height on pain and functional outcome. Evaluation of ChatGPT-5 responses to patient-centered questions on stromal vascular fraction for knee osteoarthritis: fair to good quality and content.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1